We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coca-Cola
KO
$354B
| $39.8M | 0.22% |
725,408
+90,367
| +14% | +$4.67M |
|
|
WORK
102
DELISTED
Slack Technologies, Inc.
WORK
| $39.7M | 0.22% |
+940,969
| New | +$31.8M |
|
|
GRMN
103
Garmin
GRMN
$46.9B
| $39.3M | 0.21% |
328,543
-68,022
| -17% | -$7.53M |
|
104
Nike
NKE
$61.9B
| $38.7M | 0.21% |
273,872
-352,282
| -56% | -$46.7M |
|
105
Tractor Supply
TSCO
$16.3B
| $36.9M | 0.2% |
1,311,060
-1,978,965
| -60% | -$55.4M |
|
106
Darling Ingredients
DAR
$9.93B
| $36.8M | 0.2% |
638,079
+433,624
| +212% | +$20.7M |
|
107
10x Genomics
TXG
$5.87B
| $36.4M | 0.2% |
257,149
+165,325
| +180% | +$24M |
|
|
TIF
108
DELISTED
Tiffany & Co.
TIF
| $36.1M | 0.2% |
274,689
-72,822
| -21% | -$9.32M |
|
109
Eli Lilly
LLY
$1.07T
| $35.8M | 0.19% |
212,214
+27,204
| +15% | +$4.06M |
|
|
ESPR
110
DELISTED
Esperion Therapeutics
ESPR
| $35.8M | 0.19% |
1,375,930
+9,825
| +0.7% | +$294K |
|
111
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $35.5M | 0.19% |
921,421
+635,182
| +222% | +$23.7M |
|
112
S&P Global
SPGI
$126B
| $35.2M | 0.19% |
106,941
-1,447
| -1% | -$488K |
|
113
Blackrock
BLK
$164B
| $33.3M | 0.18% |
46,091
-21,261
| -32% | -$14.1M |
|
114
ON Semiconductor
ON
$33.8B
| $33.3M | 0.18% |
+1,016,062
| New | +$28.3M |
|
115
Brown-Forman Class B
BF.B
$12B
| $32.4M | 0.18% |
408,420
+128,366
| +46% | +$9.91M |
|
116
Medtronic
MDT
$107B
| $32.1M | 0.17% |
274,119
-554,526
| -67% | -$61M |
|
117
Chegg
CHGG
$108M
| $32.1M | 0.17% |
355,423
+344,341
| +3,107% | +$27.4M |
|
118
McKesson
MCK
$98.5B
| $31.6M | 0.17% |
181,609
+66,094
| +57% | +$11M |
|
119
Linde
LIN
$237B
| $31.6M | 0.17% |
120,737
-171,944
| -59% | -$42.2M |
|
120
Zimmer Biomet
ZBH
$17.7B
| $31M | 0.17% |
207,038
+37,996
| +22% | +$5.37M |
|
121
Best Buy
BBY
$18B
| $30.9M | 0.17% |
309,982
-77,321
| -20% | -$8.65M |
|
122
Graphic Packaging
GPK
$3.26B
| $30.8M | 0.17% |
1,816,094
-241,186
| -12% | -$3.65M |
|
123
Pinduoduo
PDD
$118B
| $30.6M | 0.17% |
172,259
+43,829
| +34% | +$5.24M |
|
124
AbbVie
ABBV
$458B
| $30.2M | 0.16% |
281,715
-235,438
| -46% | -$22.6M |
|
125
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $30M | 0.16% |
+552,400
| New | +$29.9M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.